A Study of Fesoterodine and Oxybutynin on Cognitive Function in Mild Cognitive Impairment
Clinical trial NCT02240459 · COMPLETED
Trial details
- NCT number
- NCT02240459
- Sponsor
- University of Alberta
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2020-01-31
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.